TCR2 THERAPEUTICS INC. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Tcr2 Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q1 2023.
  • Tcr2 Therapeutics Inc. Earnings Per Share, Basic for the quarter ending March 31, 2023 was -1.03 USD/shares, a 35.5% decline year-over-year.
  • Tcr2 Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2023 was -4.2 USD/shares.
  • Tcr2 Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -3.93 USD/shares, a 49.4% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$4 -$1 $0 -35.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$4 -$2 Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 -$1 $0 -14.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$1 $0 -28.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.